Enristas 4 MF Tablet PR
By Enristas MF
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(4mg) + Metformin(1000mg)

Manufacturer - Anthem Biopharma
No 49, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Hosur Road, Bangalore 560 099, Karnataka, India.

Expires on or after
February, 2027

liver
When using Enristas 4 MF Tablet PR, it is important to be cautious if you have any liver disease. Your doctor may need to adjust the dose of the medication accordingly. Typically, Enristas 4 MF Tablet PR is initiated at a low dose for patients with mild to moderate liver disease. However, it is not advisable to use this medication if you have severe liver disease. If you have a history of liver diseases or conditions, extra care should be taken when taking Enristas 4 MF Tablet PR, and the dosage may be modified by your doctor if necessary.

kidney
Caution should be observed when using Enristas 4 MF Tablet PR in patients with kidney disease. Dose adjustment may be necessary, and it is not recommended for those with severe kidney issues. Regular kidney function monitoring is advised during treatment.

alcohol
It is unsafe to consume alcohol with Enristas 4 MF Tablet PR. Avoid alcohol with Glador M4 Forte Tablet 15's to prevent risk of lactic acidosis.

driving
Caution - Driving Your driving ability can be influenced by low or high blood sugar levels. Do not drive if experiencing these symptoms. Glador M4 Forte Tablet 15's can reduce alertness in some individuals. Drive only when fully alert after taking the tablet.

pregnancy
Enristas 4 MF Tablet PR may not be safe for use during pregnancy, as studies in animals have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing it. Please consult your doctor if pregnant.

breastfeeding
It is unsafe to breastfeed while taking Enristas 4 MF Tablet PR, as it may harm the baby due to potential drug toxicity. Please consult a doctor before using this medication if you are breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹224
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024